Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Clinical Oncology: Case Reports
Pablo Bedano (USA) Author
Subjects of specialization
Affiliation
Hematology Medical Oncology,Thoracic Cancer,Tumor,Breast Cancer
"Hematology, Medical Oncology Doctor and Indianapolis, 1 Community Hospital Oncology Physicians"
Biography
Pablo Bedano, M.D., is board certified in internal medicine, medical oncology and hematology. He completed his residency and a hematology oncology fellowship at Indiana University School of Medicine. In addition, he holds a master?s degree in clinical research and has been involved in multiple clinical trials. Dr. Bedano?s areas of special interest and expertise are genitourinary malignancies, head and neck cancers, thoracic oncology, breast cancer and melanoma. In addition to his clinical research experience, he has been published in numerous medical journals and awarded several grants, awards and fellowships.
Publications
Case Report Open Access
Impressive Response to Immunotherapy in a Patient with Metastatic Adrenocortical Carcinoma
Author(s): Lindsey Addington*, Hagman Thomas, Hawk, Nicole CMA and Pablo Bedano (USA)
Adrenocortical carcinoma (ACC) is a rare cancer with limited effective treatment options and poor prognosis. ACC incidence is 1 to 2 cases per million making randomized clinical trials difficult to conduct. The current standard first line treatment for metastatic ACC showing tumor response and improved progression free survival (PFS) is etoposide-doxorubicin-cisplatin (EDP) plus mitotane. Multiple efforts to find a targeted treatment for ACC have not shown impressive responses. Immunotherapy agents such as checkpoint inhibitors programmed cell death – 1 receptor (PD-1) and programmed cell deathligand 1 have shown significant responses in multiple malignancies including melanoma, non-small-cell-lung cancer, Hodgkin’s lymphoma to name a few. We present a case of a female patie... view more»